MoneyWorks4Me

Zydus Lifesciences informs about press release

14 Mar 2024 Evaluate
Zydus Lifesciences has informed that it enclosed a copy of press release dated March 14, 2024 titled ‘Zydus receives Final Approval from the USFDA for Chlorpromazine Hydrochloride Injection USP, 25 mg/mL and 50 mg/2 mL (25 mg/mL), Single-Dose Vials’.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1744.35
Dr. Reddys Labs. 1238.05
Cipla 1324.00
Lupin 1931.40
Zydus Lifesciences 1111.00
View more..